Friday, 11 August 2017

Sun Pharma Q1


Consol Net Loss at Rs 425 Cr Vs PAT Rs 2,034 Cr YoY

Consol Net Sales at Rs 6,208 Cr Vs Rs 8,256 Cr YoY

One-time loss of 950.5 cr

EBITDA At Rs 1,096 Cr Vs CNBC-TV18 Poll Of Rs 1,744.5 Cr

EBITDA margin at 17.6% Vs CNBC-TV18 poll of 24.6% 

Exceptional expense of ₹950 cr  on litigation

No comments:

Post a Comment